UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000007373
Receipt No. R000008682
Scientific Title Evaluation of mimimally invasive palliative therapy by Transcatheter arterial chemoembolization for unresectable recurrent head and neck cancer
Date of disclosure of the study information 2012/02/24
Last modified on 2012/02/24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Evaluation of mimimally invasive palliative therapy by
Transcatheter arterial chemoembolization
for unresectable recurrent head and neck cancer
Acronym Evaluation of TACE
for unresectable recurrent head and neck cancer
Scientific Title Evaluation of mimimally invasive palliative therapy by
Transcatheter arterial chemoembolization
for unresectable recurrent head and neck cancer
Scientific Title:Acronym Evaluation of TACE
for unresectable recurrent head and neck cancer
Region
Japan

Condition
Condition Head and neck cancer
Classification by specialty
Oto-rhino-laryngology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Evaluation of TACE unresectable recurrent head and neck cancer with bleeding
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes efficacy of hemostasis,
duration of hemostasis,
duration of hospitalization after treatment,
pain control,
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine Maneuver
Interventions/Control_1 TACE
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1, Patient age 20 years and above
2, unresectable recurrent head and neck cancer after common therapy
3, bleeding for cutaneous and mucosal invasion or high risk of bleeding
4, no other effective treatment
5, Patients who were provided written informed consent
Key exclusion criteria 1, pregnancy or lactating women or women with suspected pregnancy
2, possibility of the remarkabke phisical damage by this treatment
3, Patient judged by the investigator to be unfit to be enrolled into the study
Target sample size 5

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Junkichi Yokoyama
Organization Juntendo university school of medicine
Division name Department of Otolaryngology, head and neck surgery
Zip code
Address 2-1-2, Hongo, Bunkyou-ku, Tokyo
TEL
Email

Public contact
Name of contact person
1st name
Middle name
Last name
Organization Juntendo university school of medicine
Division name Department of Otolaryngology, head and neck surgery
Zip code
Address
TEL 03-3813-1605
Homepage URL
Email

Sponsor
Institute Juntendo university school of medicine
Institute
Department

Funding Source
Organization Health and Labor Science Reserch Grant for Clinical Cancer Reserch
Organization
Division
Category of Funding Organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2012 Year 02 Month 24 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2012 Year 02 Month 21 Day
Date of IRB
Anticipated trial start date
2012 Year 03 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2012 Year 02 Month 24 Day
Last modified on
2012 Year 02 Month 24 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008682

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.